Cannabinoids

CDMO Activity Tracker: CDMOs expand operations in cell and gene therapies, biologics, HPAPIs

The Covid-19 pandemic expedited the growth of contract development and manufacturing organizations

DMF submissions rise 12.1% in 2022; India sees 10.6% drop in Type II filings

In 2022, the world finally began to emerge out of Covid-related restrictions. Though 2020 and 2021

Cannabinoids in pharmaceutical development

The development of cannabinoids in the pharmaceutical industry has exploded over the past few year

Sales Forecast of FDA’s Novel Drugs Approvals in 2018

The year 2018 was a landmark year for the US Food and Drug Administration (FDA) as the agency approv

Marijuana Based Medicines – highway to pots of gold

Legally cultivated cannabis, in some parts of the United States, resulted in a boom, which could ne